Back to search

Article

Frequency of metabolic syndrome and insulin resistance in epileptic patients treated with sodium valproate or carbamazepine monotherapy: A Case-Control Study 

2021-01-04

Abstract excerpt

<title>Abstract</title> <p>Background Metabolic syndrome (MetS) represents a collection of metabolic risk factors such as obesity, dyslipidemia, hyperglycemia, and hypertension. Medications can increase the incidence rate of MetS and insulin resistance (IR). Objective This study aims to evaluate the effects of Carbamazepine (CBZ) or Valproate (VPA) as monotherapy on the development of MetS and IR in the adult I...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
62015bf0-f072-5cfe-9a68-62a7aa646931
DOI
10.21203/rs.3.rs-131323/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Frequency of metabolic syndrome and insulin resistance in epileptic patients treated with sodium valproate or carbamazepine monotherapy: A Case-Control StudyDOI 10.21203/rs.3.rs-131323/v1
Select a neighboring publication to make it the new centre.